Heartbeam, Inc. ( (BEAT) ) has released its Q3 earnings. Here is a breakdown of the information Heartbeam, Inc. presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
HeartBeam, Inc. is a medical technology company specializing in advanced cardiac monitoring solutions, focusing on developing portable, high-resolution ECG devices for detecting and monitoring cardiac diseases outside healthcare facilities. The company recently released its quarterly earnings report, highlighting ongoing financial challenges and strategic developments. HeartBeam reported a net loss of $5.3 million for the third quarter of 2025, an increase from the previous year, primarily due to higher research and development expenses. Despite the financial losses, the company achieved significant milestones, including FDA clearance for its HeartBeam System and advancements in its AI program. Looking ahead, HeartBeam plans to continue its focus on commercial readiness and strategic collaborations to enhance its product offerings, while addressing financial uncertainties through potential capital raises.